Dowling & Yahnke’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,602
| Closed | -$246K | – | 342 |
|
|
2020
Q4 | $246K | Sell |
2,602
-106
| -4% | -$10K | 0.02% | 299 |
|
|
2020
Q3 | $235K | Buy |
2,708
+400
| +17% | +$34.7K | 0.02% | 287 |
|
|
2020
Q2 | $202K | Buy |
+2,308
| New | +$202K | 0.02% | 284 |
|
|
2020
Q1 | – | Sell |
-2,452
| Closed | -$232K | – | 357 |
|
|
2019
Q4 | $232K | Sell |
2,452
-41
| -2% | -$3.88K | 0.02% | 286 |
|
|
2019
Q3 | $217K | Hold |
2,493
| – | – | 0.02% | 291 |
|
|
2019
Q2 | $228K | Sell |
2,493
-128
| -5% | -$11.7K | 0.02% | 277 |
|
|
2019
Q1 | $226K | Buy |
2,621
+160
| +7% | +$13.8K | 0.02% | 245 |
|
|
2018
Q4 | $202K | Buy |
+2,461
| New | +$202K | 0.02% | 243 |
|
|
2018
Q1 | – | Sell |
-2,834
| Closed | -$213K | – | 290 |
|
|
2017
Q4 | $213K | Hold |
2,834
| – | – | 0.02% | 281 |
|
|
2017
Q3 | $218K | Sell |
2,834
-159
| -5% | -$12.2K | 0.02% | 269 |
|
|
2017
Q2 | $224K | Sell |
2,993
-414
| -12% | -$31K | 0.02% | 262 |
|
|
2017
Q1 | $227K | Buy |
+3,407
| New | +$227K | 0.02% | 259 |
|
|
2016
Q4 | – | Sell |
-2,875
| Closed | -$203K | – | 270 |
|
|
2016
Q3 | $203K | Sell |
2,875
-202
| -7% | -$14.3K | 0.02% | 255 |
|
|
2016
Q2 | $227K | Buy |
+3,077
| New | +$227K | 0.03% | 251 |
|
|
2016
Q1 | – | Sell |
-5,334
| Closed | -$411K | – | 261 |
|
|
2015
Q4 | $411K | Buy |
5,334
+2,483
| +87% | +$191K | 0.05% | 208 |
|
|
2015
Q3 | $235K | Buy |
2,851
+158
| +6% | +$13K | 0.03% | 236 |
|
|
2015
Q2 | $237K | Hold |
2,693
| – | – | 0.03% | 242 |
|
|
2015
Q1 | $238K | Sell |
2,693
-255
| -9% | -$22.5K | 0.03% | 235 |
|
|
2014
Q4 | $245K | Buy |
2,948
+98
| +3% | +$8.15K | 0.03% | 238 |
|
|
2014
Q3 | $240K | Sell |
2,850
-175
| -6% | -$14.7K | 0.03% | 229 |
|
|
2014
Q2 | $245K | Buy |
3,025
+296
| +11% | +$24K | 0.03% | 245 |
|
|
2014
Q1 | $208K | Buy |
+2,729
| New | +$208K | 0.03% | 263 |
|